MAC Clinical Research
MAC Clinical Research is a full-service, global contract research organisation (CRO) headquartered in the UK, operating a fully owned network of dedicated research sites.
Last updated September 16, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
MAC Clinical Research is a full-service, flexible, global Contract Research Organisation (CRO) with headquarters in the UK. It owns a network of Dedicated Research Sites and also has offices within the EU and the US. Its service areas include Phase 1 clinical trials, biometrics, laboratory services (bioanalytical and pathology), pharmaceutical services including GMP manufacturing, a sleep laboratory, and patient engagement through MAC EnVision®. The company states it has built a fully owned network of clinical sites over the last 30 years.
History
MAC Clinical Research describes itself as a full-service, global pharmaceutical contract research organisation (CRO) that has built a fully owned network of clinical sites over the last 30 years. Its published history timeline records milestones including: 2008 (patient enrolment, recruitment and retention centre established); 2009 (CliniSafe wins SCRIP award for Best Technological Award in Clinical Trials); 2010 (CliniSafe wins SCRIP award); 2011 (Queen's Award; research facility opens in the Midlands; Institute of Directors North West Director of the Year Awards — Mark Dale wins award for Business Innovation); 2013 (Pharmacy Department opens first aseptic services suite in Manchester); 2014 (Pharmacy Department opens aseptic services suite in Leeds; Memory Assessment and Research Centre opens in Leeds); 2015 (wins Health and Care Business of The Year at the Red Rose Awards 2015; Neuroscience Centre of Excellence opens at Citylabs 1.0 in Manchester); 2016 (Dedicated Research Centre opens in Barnsley; GMP Pharmaceutical Manufacturing facilities open in Leeds; Dedicated Research Centre opens in Liverpool; Manchester Phase 1 Unit receives MHRA Phase 1 Accreditation; CEO Dr Mark Dale awarded Honorary Membership of the Faculty of Pharmaceutical Medicine); 2017 (Dedicated Research Centre opens in Stockton on Teesside; Biometrics services commence); 2018 (Sleep Laboratory opens at Liverpool Clinic); 2020 (Contract Research Services: a full-service CRO); 2021 (MAC Incorporated in Ireland; first USA office opens in Philadelphia; Pharmacovigilance Services); 2023 (MAC Incorporated in Australia; MAC Incorporated in Pakistan); 2024 (Dedicated Research Centre opens in Glasgow following MAC's acquisition of Intelligent Clinical).
Products and positioning
Full-service, flexible, global Contract Research Organisation with a fully owned network of dedicated research sites.
Product categories. Phase I clinical trials · Biometrics solutions · Bioanalytical and pathology laboratory services · GMP pharmaceutical manufacturing · Sleep laboratory / polysomnography · Patient engagement (MAC EnVision®)
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/mac-clinical-research-united-kingdom · Editorial policy · How profiles are compiled